IRIS
FABRIS, Martina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.347
AS - Asia 4.828
EU - Europa 3.339
SA - Sud America 864
Continente sconosciuto - Info sul continente non disponibili 389
AF - Africa 121
OC - Oceania 12
Totale 19.900
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.146
SG - Singapore 2.211
CN - Cina 943
IT - Italia 741
BR - Brasile 666
UA - Ucraina 632
HK - Hong Kong 480
DE - Germania 469
VN - Vietnam 424
FI - Finlandia 290
RU - Federazione Russa 275
FR - Francia 235
IN - India 178
GB - Regno Unito 165
IE - Irlanda 157
BD - Bangladesh 117
SE - Svezia 114
TR - Turchia 102
CA - Canada 98
AR - Argentina 60
KR - Corea 56
MX - Messico 53
AT - Austria 42
IQ - Iraq 42
JP - Giappone 42
ZA - Sudafrica 42
ES - Italia 37
NL - Olanda 37
ID - Indonesia 36
EC - Ecuador 34
PL - Polonia 30
BE - Belgio 29
CO - Colombia 25
SA - Arabia Saudita 24
PK - Pakistan 23
IR - Iran 22
PY - Paraguay 21
PH - Filippine 20
VE - Venezuela 17
CL - Cile 16
MA - Marocco 16
EG - Egitto 13
AZ - Azerbaigian 12
JM - Giamaica 11
TG - Togo 11
UZ - Uzbekistan 11
AU - Australia 10
LT - Lituania 10
DO - Repubblica Dominicana 9
IL - Israele 9
PE - Perù 9
RS - Serbia 9
TN - Tunisia 9
CH - Svizzera 8
MY - Malesia 8
RO - Romania 8
AE - Emirati Arabi Uniti 7
AL - Albania 7
BO - Bolivia 7
BY - Bielorussia 7
CZ - Repubblica Ceca 7
KZ - Kazakistan 7
NP - Nepal 7
UY - Uruguay 7
KG - Kirghizistan 6
OM - Oman 6
CR - Costa Rica 5
DZ - Algeria 5
EE - Estonia 5
KE - Kenya 5
LB - Libano 5
AM - Armenia 4
BB - Barbados 4
ET - Etiopia 4
EU - Europa 4
HN - Honduras 4
HU - Ungheria 4
JO - Giordania 4
PA - Panama 4
PT - Portogallo 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
BG - Bulgaria 3
HR - Croazia 3
KH - Cambogia 3
NI - Nicaragua 3
PS - Palestinian Territory 3
BH - Bahrain 2
BN - Brunei Darussalam 2
BS - Bahamas 2
BW - Botswana 2
DK - Danimarca 2
LV - Lettonia 2
NG - Nigeria 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TW - Taiwan 2
AO - Angola 1
BF - Burkina Faso 1
CI - Costa d'Avorio 1
Totale 19.489
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.008
Singapore 962
Ashburn 793
Ann Arbor 769
Chandler 657
Fairfield 654
Houston 537
Beijing 491
San Jose 477
Hong Kong 472
Jacksonville 438
Wilmington 316
Dearborn 287
Seattle 265
Council Bluffs 259
Boardman 222
Cambridge 200
Udine 163
Lauterbourg 155
Los Angeles 154
Dublin 151
Princeton 145
Dallas 130
Ho Chi Minh City 123
Helsinki 94
Santa Clara 89
Munich 79
New York 79
Izmir 77
Hanoi 75
Dong Ket 70
Buffalo 65
Redondo Beach 64
Trieste 64
The Dalles 63
Hefei 62
San Diego 60
São Paulo 60
Redmond 56
Seoul 48
Frankfurt am Main 38
Milan 38
Orem 38
Norwalk 37
Ogden 36
Montreal 35
Tokyo 35
Venezia 35
Nuremberg 31
Brussels 27
Denver 26
Des Moines 26
Mumbai 26
Nanjing 26
Phoenix 26
Warsaw 26
Guangzhou 25
Johannesburg 25
London 24
Ottawa 24
Belluno 23
Chicago 23
Atlanta 22
Brooklyn 22
Chennai 22
Düsseldorf 22
Amsterdam 21
Rio de Janeiro 21
San Mateo 21
Belo Horizonte 19
Mexico City 19
Stockholm 19
Poplar 18
Toronto 18
Vienna 18
Baghdad 17
Leawood 17
Rome 17
Boston 16
Augusta 15
Da Nang 15
San Francisco 15
Kunming 14
Lappeenranta 14
Grafing 13
New Delhi 13
Querétaro 13
Turku 13
Miami 12
Paris 12
Salvador 12
Baku 11
Codroipo 11
Guayaquil 11
Jeddah 11
Lomé 11
Naples 11
Tavagnacco 11
Venice 11
Curitiba 10
Totale 12.171
Salva come PNG Salva come JPEG
Nome #
Characterization of the Proinflammatory Profile of Synovial Fluid-Derived Exosomes of Patients with Osteoarthritis 285
Exploring the plasmatic platelet-activating factor acetylhydrolase activity in patients with anti-phospholipid antibodies 281
Pro inflammatory stimuli enhance the immunosuppressive functions of adipose mesenchymal stem cells-derived exosomes 246
Twist is substrate for caspase cleavage and proteasome-mediated degradation 211
ADMA as a possible marker of endothelial damage. A study in young asymptomatic patients with cerebral small vessel disease. 211
Efficacy and safety of belimumab in primary Sjogren's syndrome: results of the BELISS open-label phase II study. 201
Potential Role of Exosomes in Countering Vedolizumab-Based Therapy in IBD Patients 201
An overview on advantages and limitations of serological assays for saRs-coV-2 infectious disease 200
Serum Interleukin-10 Levels Correlate with Cerebrospinal Fluid Amyloid Beta Deposition in Alzheimer Disease Patients 196
Anti-zinc transporter protein 8 autoantibodies significantly improve the diagnostic approach to type 1 diabetes: an Italian multicentre study on paediatric patients 189
AB0695 Anti-prothrombin/phosphatidyl-serine complex autoantibodies in antiphospholipid syndrome: Preliminary data using a new ELISA method 183
Anti-β2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies exert similar pro-thrombotic effects in peripheral blood monocytes and endothelial cells 182
Cardiovascular Complications of Acromegaly. 176
The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis 174
Exploring the Possible Prognostic Role of B-Lymphocyte Stimulator (BLyS) in a Large Series of Patients with Neuroendocrine Tumors 172
Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization. 169
Coeliac disease in infants: antibodies to deamidated gliadin peptide come first! 165
BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands 163
Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome 159
Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy. 157
Anti-vimentin/cardiolipin complex autoantibodies in antiphospholipid syndrome: preliminary data using a new ELISA method. 157
The role of B-lymphocyte stimulator in neuroendocrine tumors: Correlation with tumor differentiation, disease status and the presence of metastases 156
The Supplementation Therapy in Autism and Response to Treatment (START) Study: An Open-Label Feasibility Trial of Ultramicronized Palmitoylethanolamide Potential to Alleviate Psychic Distress among Autistic Adults 155
BLyS and April serum levels in patients with autoimmune thyroid diseases. 155
Clinical applications of microenvironment-controlled immunosuppressive properties of mesenchymal stem cells-derived exosomes: a review 153
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis 152
Characterization of the Proinflammatory Profile of Synovial Fluid-Derived Exosomes of Patients with Gonarthrosis. 152
Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care 151
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study. 151
Brain Endothelial Cells Activate Neuroinflammatory Pathways in Response to Early Cerebral Small Vessel Disease (CSVD) Patients’ Plasma 148
Role e of oral cyclophosphamide in the treatment of giant cell arteritis 148
Asymmetrical Dimethylarginine (ADMA) In Asympomatic Cerebral Small Vessel Disease. 147
B-lymphocyte stimulator and a proliferation-inducing ligand serum levels in IgA-deficient patients with and without celiac disease 146
BLyS Role in the Diagnosis and Prognosis of Neuroendocrine Tumors: Preliminary Results. 145
L. Quartuccio, M. Fabris, M. Maset, E. Pontarini, A. Zabotti, S. De Vita Bone marrow b-cell expansion in mixed cryoglobulinemia: association with nephritis and response to rituximab 144
The introduction of anti-phosphatidylserine/prothrombin autoantibodies in the laboratory diagnostic process of anti-phospholipid antibody syndrome: 6 months of observation 143
The Detection of Anti-adalimumab Antibodies in a Series of Inflammatory Polyarthritis: three ELISA Methods Compared 143
B lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis 142
Epidemiology of paraneoplastic neurological syndromes: a population-based study 142
Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy. 137
Pharmacogenetic Determinants of Response to Infliximab in Pediatric Inflammatory Bowel Disease. 137
Combining Deep Phenotyping of Serum Proteomics and Clinical Data via Machine Learning for COVID-19 Biomarker Discovery 137
B-Lymphocyte Stimulator in Neuroendocrine Tumors: Correlation with Disease Behavior 135
High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients 135
Do circulating exosomes interfere with vedolizumab efficacy in IBD patients? 134
Development of type II mixed cryoglobulinaemic syndrome after effective and persistent hepatitis C virus eradication. 133
Rheumatoid factor positivity, a lower disability and a lower number of anti-tnf agents failed are associated with response to rituximab in rheumatoid arthritis 127
Efficacy of belimumab and targeting of rheumatoid factor-positive B-cell expansion in Sjögren's syndrome: follow-up after the end of the phase II open-label BELISS study 126
The-308 TNFα and the -174 IL-6 promoter polymorphisms associate with effective anti-TNFα treatment in seronegative spondyloarthritis 125
Elevated B cell-activating factor of the tumour necrosis factor family in coeliac disease 125
Comparison between Anti-β2Glycoprotein I Antibody and Anti-Phosphatidylserine/Prothrombin Antibody Biological Effects on Peripheral Blood Monocytes 125
The role of the il-6 promoter p in predicting rituximab efficacy in rheumatoid artolymorphism 124
HCV-NS3 and IgG-Fc crossreactive IGM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations 124
Elevated Plasma Platelet-Activating Factor Acetylhydrolase Activity is Significantly Associated with High Risk Anti-Phospholipid Antibody Antigenic Specificities . 124
B-Lymphocyte Stimulator (BLyS) in mixed cryoglobulinemia sindrome: pathobiological and clinical implication 122
-238 AND +489 TNF-ALPHA ALONG WITH TNF-RII GENE POLYMORPHISMS ASSOCIATE WITH THE DIFFUSE PHENOTYPE IN PATIENTS WITH SYSTEMIC SCLEROSIS 122
Is the Asymmetric Dimethylarginine (ADMA) the Possible Molecule Driving Endothelial Damage in Young Asymptomatic Patients with Cerebral Small Vessel Disease? 122
Creutzfeldt-Jakob disease after COVID-19: infection-induced prion protein misfolding? A case report 121
Safety of Rituximab in different rheumatic autoimmune diseases. A single centre experience in 85 cases. 2008 121
Disappearance of bone marrow B cell clonal expansion in patients with type II hepatitis C virus-related cryoglobulinemic glomerulonephritis after clinical efficient rituximab therapy. 121
Association be tween B cell clonal expansion and glomerulonephritis in type cryoglobulinnaemia 121
Association be tween B cell clonal expansion and glomerulonephritis in type cryoglobulinnaemia. 2007; 66 (Suppl. II): 121 120
prevalence of chlamydophila psittaci subclinical infection in italian patients with rheumatoid arthritis: etiopathological and therapeutic implications 119
Chlamydophila psittaci subclinical infection in chronic polyarthritis 119
Detection of DNA of Chlamydophila psittaci in subjects with psoriasis: a casual or a causal link? 119
Characterization of Parotid Gland Epithelial Cell Primary Cultures from Patients Affected by Sjogren’s Syndrome 119
Association between bone marrow B cell clonal expansion and glomerulonephritis in type II mixed cryoglobulinaemia 118
Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis 118
Efficacy of Belimumab On Non-Malignant Parotid Swelling and Systemic Manifestations of Sjo¨gren’s Syndrome: Results of the Beliss Study. 117
Post–COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients 116
TNF-alpha gene polymorphisms in rheumatoid arthritis patient treated with anti-TNF- alpha agents: preliminary results 114
Fibronectin gene polymorphisms and clinical manifestations of mixed cryoglobulinemic syndrome: increased risk of lymphoma associated to MspI DD and HaeIII AA genotypes 114
High prevalence of Chlamydophila psittaci subclinical infection in Italian patients with Sjögren's syndrome and parotid gland marginal zone B-cell lymphoma of MALT-type. 112
Non-malignant lymphoproliferation in Sjögren’s syndrome: proposed classification based on integrated clinico-pathologic and molecular studies and follow-up. 112
Blys Promoter Polymorphism And Response To Rituximab In Rheumatoid Arthritis (RA) Patients Positive Or Negative For The Rheumatoid Factor 112
Cytokines from Bench to Bedside: A Retrospective Study Identifies a Definite Panel of Biomarkers to Early Assess the Risk of Negative Outcome in COVID-19 Patients 112
The impact of body composition on mortality of COVID-19 hospitalized patients: A prospective study on abdominal fat, obesity paradox and sarcopenia 111
Rituximab in mixed cryoglobulinemia: increased experience and perspectives 111
Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination 111
Rankl and osteoprotegerin serum levels changes after rituximab therapy in rheumatoid arthritis: correlation with disease control and bone mineral density preservation 110
A Multiparametric Method Improves the Serological Characterization of Inflammatory Bowel Diseases: Preliminary Results from a Multicenter Eastern Europe Study 109
Toll-like Receptor-4 Activation Boosts the Immunosuppressive Properties of Tumor Cells-derived Exosomes 109
Stroke-Like Presentation of Paraneoplastic Cerebellar Degeneration: a Single-Center Experience and Review of the Literature 109
Circulating exosomes express α4β7 integrin and compete with CD4+ T cells for the binding to Vedolizumab 109
The TTTT BLyS promoter haplotype associates with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to TNF blockers. 108
Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study 108
BlYS Promoter Polymorphins and Response to Rituximab in Rheumatoid Arthritis (RA) patients positive or negative for Rheumatoid Factor, , vol 60 suppl 10 :1678 107
Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia. 107
Tumor necrosis factor-alpha gene polymorphism in severe and mild -moderate rheumatoid arthritis. 107
Efficacy and Safety of High-Dose Immunoglobulin-Based Regimen in Statin-Associated Autoimmune Myopathy: A Multi-Center and Multi-Disciplinary Retrospective Study 107
Assessing the biobehavioral effects of ultramicronized-palmitoylethanolamide monotherapy in autistic adults with different severity levels: a report of two cases 106
Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune response, or both? 106
Higher levels of IL-6 early after tocilizumab distinguish survivors from non-survivors in COVID-19 pneumonia: a possible indication for deeper targeting IL-6 106
Extracellular vesicle features are associated with COVID-19 severity 105
Central nervous system immune-related disorders after SARS-CoV-2 vaccination: a multicenter study 104
Safety of Rituximab in different rheumatic autoimmune diseases. A single centre experience in 85 cases. 104
Fibronectin plasma levels and gene polymorphisms in aggressive RA patients treated with anti-TNF-alpha agents. 104
Preliminary Evaluation of a new immunofluorescence mosaic assay for inflammatory bowel disease diagnosis: a pilot study in Udine 104
Italy association of transforming growth factor-b (tgf-b) 869cc polymorphism with bone erosions in rheumatoid arthritis: an ultrasonographic study. 103
Efficacy and safety of belimumab given for 12 months in primary Sjögren's syndrome: the BELISS open-label phase II study 103
Totale 13.858
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.193
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.193
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.147 62 122 35 94 51 29 44 62 13 176 280 179
2022/20231.542 167 116 9 234 126 382 23 136 206 18 65 60
2023/2024499 73 37 24 15 75 62 13 54 58 46 12 30
2024/20253.244 83 213 228 136 118 142 233 196 354 276 495 770
2025/20266.552 531 572 510 780 860 533 692 192 529 524 486 343
2026/2027166 166 0 0 0 0 0 0 0 0 0 0 0
Totale 19.900